Financial statements Filler Pharma
Balance sheet of Filler Pharma
Company age:
Age:
6 y. 8 m. 1 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of FILLER PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 28 494,44 | 94 703,05 | 489 487,34 | 819 614,20 | 1 043 729,91 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 28 494,44 | 94 703,05 | 489 487,34 | 819 614,20 | 1 043 729,91 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | -32 814,05 | 94 703,05 | 489 487,34 | 819 614,20 | 1 043 729,91 |
| A. Equity | -54 517,46 | -39 236,29 | 189 220,80 | 355 119,67 | 550 028,25 |
| B. Liabilities and provisions for liabilities | 21 703,41 | 133 939,34 | 300 266,54 | 464 494,53 | 493 701,66 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 21 703,41 | 133 939,34 | 300 266,54 | 464 494,53 | 493 701,66 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.